4.7 Review

The Gut Microbiota in Inflammatory Bowel Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn's disease: an open-label multicentre randomised controlled trial

Maria M. E. Jongsma et al.

Summary: In paediatric patients with moderate-to-severe Crohn's disease, starting with infliximab (IFX) as first-line treatment (FL-IFX) is more effective in achieving and maintaining remission compared to conventional treatment.
Editorial Material Gastroenterology & Hepatology

Upadacitinib for Crohn's Disease and Ulcerative Colitis Treatment: Hitting the Selective JAKpot

Tommaso Lorenzo Parigi et al.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD

Shixian Hu et al.

Summary: This study reveals that both common and rare genetic variants affecting the immune system are crucial in shaping the gut microbiota of patients with inflammatory bowel disease, highlighting potential mechanisms for disease treatment.
Article Gastroenterology & Hepatology

Crohn's Disease Pathobiont Adherent-Invasive E coli Disrupts Epithelial Mitochondrial Networks With Implications for Gut Permeability

Nicole L. Mancini et al.

Summary: LF82 E coli infection caused significant disruption of epithelial mitochondrial function and structure, leading to mitochondrial fragmentation and dysfunction. Inhibitors targeting mitochondrial fission partially reduced the observed effects, suggesting potential strategies to maintain cellular homeostasis and mitigate infection-induced epithelial barrier dysfunction.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Biochemistry & Molecular Biology

Exploring the Role of Gut Microbiome in Colon Cancer

Indranil Chattopadhyay et al.

Summary: The dysbiosis of the gut microbiome is associated with the development of colorectal cancer, with alterations in gut microbiota composition potentially being a potential therapeutic approach. Probiotics such as Lactobacillus and Bifidobacterium inhibit CRC growth through various mechanisms, and the interaction between lifestyle, host genetics, and gut microbiota is crucial in the prevention and treatment of CRC.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2021)

Article Microbiology

Immunoglobulin A Targets a Unique Subset of the Microbiota in Inflammatory Bowel Disease

Jason M. Shapiro et al.

Summary: The immunopathogenesis of inflammatory bowel disease (IBD) is linked to host genetics and intestinal dysbiosis. Investigating IgA responses to microbiota can reveal potential disease-modifying taxa and improved biomarkers of clinical course in IBD.

CELL HOST & MICROBE (2021)

Article Gastroenterology & Hepatology

Long-term Safety of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection

Srishti Saha et al.

Summary: Fecal microbiota transplantation (FMT) is highly effective for treating recurrent Clostridioides difficile infection (CDI) and appears to be safe. Common symptoms during short-term follow-up include diarrhea and constipation, while long-term follow-up revealed new diagnoses that should be further explored in future studies.

GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Inflammatory Bowel Diseases (IBD) and the Microbiome-Searching the Crime Scene for Clues

Mirae Lee et al.

Summary: Inflammatory bowel diseases (IBD) result from the interaction of environmental, microbial, immunological, and genetic factors, with alterations in the gut microbiota playing a role in their development and progression. The use of microbiome-based therapies can potentially prevent, manage, and cure IBD, bridging the gap between basic sciences and clinical application through research findings.

GASTROENTEROLOGY (2021)

Article Biochemistry & Molecular Biology

Microbiota-Derived Metabolites, Indole-3-aldehyde and Indole-3-acetic Acid, Differentially Modulate Innate Cytokines and Stromal Remodeling Processes Associated with Autoimmune Arthritis

David Langan et al.

Summary: The study revealed that indole-3-aldehyde and indole-3-acetic acid have different biological activities in influencing the pathogenesis of rheumatoid arthritis. Indole-3-aldehyde can inhibit pro-inflammatory cytokine expression and exhibit pro-angiogenic and pro-osteoclastogenic activities, while indole-3-acetic acid has anti-angiogenic effects and no impact on osteoclastogenesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Medicine, General & Internal

Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?

Sara Deleu et al.

Summary: Short-chain fatty acids play important roles in the gut microbiome and intestinal immune system, exerting various effects on host metabolism and immune system. Further research is needed on the cross-feeding mechanisms in the gut microbiome and the therapeutic potential of SCFAs in different disease models.

EBIOMEDICINE (2021)

Article Medicine, General & Internal

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

Brian G. Feagan et al.

Summary: The study assessed the efficacy and safety of filgotinib in treating ulcerative colitis, with the results showing that 200 mg of filgotinib was more effective than placebo in inducing and maintaining clinical remission.

LANCET (2021)

Article Multidisciplinary Sciences

Microbes exploit death-induced nutrient release by gut epithelial cells

Christopher J. Anderson et al.

Summary: The study demonstrates how nutrients released from apoptotic cells can promote the growth of Enterobacteriaceae and highlights the role of pyruvate formate-lyase-encoding pflB gene in bacterial colonization in various contexts. These findings provide new insights into host-pathogen interactions and have implications for gut inflammation and chemotherapy treatment.

NATURE (2021)

Article Gastroenterology & Hepatology

The role of oral bacteria in inflammatory bowel disease

Emily Read et al.

Summary: This perspective discusses the potential direct role of oral-associated bacteria in the pathogenesis of inflammatory bowel disease, suggesting that these bacteria may exacerbate inflammation in the intestine. Changes in the oral bacterial microbiota are associated with various inflammatory conditions, and it is proposed that oral disease-associated bacteria could translocate to the intestine and directly worsen the disease. The evidence supporting this hypothesis is critically evaluated in the context of other diseases where oral bacteria have been implicated.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?

Atsushi Nishida et al.

Summary: Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal tract, involving Crohn's disease and ulcerative colitis, with aberrant immune activation possibly caused by genetic susceptibility and environmental factors. Studies have shown dysbiosis and altered metabolites from the gut microbiota to play a role in IBD pathogenesis. Interventions like fecal microbiota transplantation (FMT) are being explored as novel therapies for IBD, but their efficacy is still debated, requiring further research validation.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Article Microbiology

Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease

Nathaniel D. Chu et al.

Summary: The study on fecal microbiota transplantation (FMT) in patients with ulcerative colitis revealed dynamic colonization and persistence of transferred microbes, along with evaluation of microbial functions, including interactions with the host immune system. This research sheds light on the potential role of transferred microbial interactions in gut microbiome therapeutics for immune related diseases.
Article Multidisciplinary Sciences

Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis

Daniel van der Lelie et al.

Summary: Environmental factors, mucosal permeability, and defective immunoregulation contribute to overactive immunity towards certain intestinal bacteria, leading to various inflammatory conditions. GUT-108 expands beneficial gut bacteria, reduces pathogens, promotes mucosal healing and immune regulation.

NATURE COMMUNICATIONS (2021)

Article Biotechnology & Applied Microbiology

Effect of Probiotic Use on Adverse Events in Adult Patients with Inflammatory Bowel Disease: a Retrospective Cohort Study

Maria Pina Dore et al.

PROBIOTICS AND ANTIMICROBIAL PROTEINS (2020)

Article Gastroenterology & Hepatology

IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease

Stephen B. Hanauer et al.

JOURNAL OF CROHNS & COLITIS (2020)

Review Gastroenterology & Hepatology

Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review

Rapat Pittayanon et al.

GASTROENTEROLOGY (2020)

Article Multidisciplinary Sciences

Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis

Xinyang Song et al.

NATURE (2020)

Review Gastroenterology & Hepatology

Gut microbiota-derived metabolites as key actors in inflammatory bowel disease

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Immunology

Interaction Between the Microbiota, Epithelia, and Immune Cells in the Intestine

Hisako Kayama et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Article Multidisciplinary Sciences

Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells

Clarissa Campbell et al.

NATURE (2020)

Editorial Material Oncology

A Microbiota-Derived Metabolite Augments Cancer Immunotherapy Responses in Mice

Emma Allen-Vercoe et al.

CANCER CELL (2020)

Review Cell Biology

The Gut Microbiota at the Service of Immunometabolism

Chloe Michaudel et al.

CELL METABOLISM (2020)

Review Gastroenterology & Hepatology

Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD

Matthew R. Kudelka et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Fecal Microbiota Alterations Associated With Clinical and Endoscopic Response to Infliximab Therapy in Crohn's Disease

Xiaojun Zhuang et al.

INFLAMMATORY BOWEL DISEASES (2020)

Article Multidisciplinary Sciences

Defined microbiota transplant restores Th17/RORγt+ regulatory T cell balance in mice colonized with inflammatory bowel disease microbiotas

Graham J. Britton et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Immunology

Host-microbiota interactions in inflammatory bowel disease

Roberta Caruso et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

Jason Lloyd-Price et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Maternal IgA protects against the development of necrotizing enterocolitis in preterm infants

Kathyayini P. Gopalakrishna et al.

NATURE MEDICINE (2019)

Review Microbiology

Microbial genes and pathways in inflammatory bowel disease

Melanie Schirmer et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Review Cell Biology

Inflammatory Bowel Disease: A Stressed Gut/Feeling

Yvonne Oligschlaeger et al.

Review Medicine, General & Internal

The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications

Jessica R. Allegretti et al.

LANCET (2019)

Article Multidisciplinary Sciences

Bile acid metabolites control TH17 and Treg cell differentiation

Saiyu Hang et al.

NATURE (2019)

Article Gastroenterology & Hepatology

Enterotoxigenic Escherichia coli heat labile enterotoxin inhibits intestinal ascorbic acid uptake via a cAMP-dependent NF-κB-mediated pathway

Ganapathy A. Subramenium et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2019)

Article Microbiology

Gut microbiome structure and metabolic activity in inflammatory bowel disease

Eric A. Franzosa et al.

NATURE MICROBIOLOGY (2019)

Article Multidisciplinary Sciences

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut

Pichet Praveschotinunt et al.

NATURE COMMUNICATIONS (2019)

Article Microbiology

Type VI Secretion Systems and the Gut Microbiota

Michael J. Coyne et al.

MICROBIOLOGY SPECTRUM (2019)

Article Gastroenterology & Hepatology

Adherent-invasive Escherichia coli in inflammatory bowel disease

Carolina Palmela et al.

Review Gastroenterology & Hepatology

Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease

Mark Fleisher et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Article Pharmacology & Pharmacy

The intriguing role of Rifaximin in gut barrier chronic inflammation and in the treatment of Crohn's disease

Loris R. Lopetuso et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)

Editorial Material Gastroenterology & Hepatology

Beyond metagenomics, metatranscriptomics illuminates microbiome functionality in IBD

Aonghus Lavelle et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Mitochondrial function - gatekeeper of intestinal epithelial cell homeostasis

Eva Rath et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Multidisciplinary Sciences

Precision editing of the gut microbiota ameliorates colitis

Wenhan Zhu et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Mechanisms regulating intestinal barrier integrity and its pathological implications

Chaithanya Chelakkot et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Article Gastroenterology & Hepatology

Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases

Betsy W. Stevens et al.

DIGESTIVE DISEASES AND SCIENCES (2017)

Article Gastroenterology & Hepatology

Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases

Susanna Nikolaus et al.

GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Diet as a Trigger or Therapy for Inflammatory Bowel Diseases

James D. Lewis et al.

GASTROENTEROLOGY (2017)

Article Oncology

Analysis of murine and human Treg subsets in inflammatory bowel disease

Xiaoyun Sun et al.

MOLECULAR MEDICINE REPORTS (2017)

Article Biotechnology & Applied Microbiology

Towards standards for human fecal sample processing in metagenomic studies

Paul I. Costea et al.

NATURE BIOTECHNOLOGY (2017)

Editorial Material Gastroenterology & Hepatology

Tofacitinib effective in ulcerative colitis

Conor A. Bradley

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Review Medical Laboratory Technology

Gut microbiome interactions with drug metabolism, efficacy, and toxicity

Ian D. Wilson et al.

TRANSLATIONAL RESEARCH (2017)

Editorial Material Gastroenterology & Hepatology

A microbial signature for Crohn's disease

Ayhan Hilmi Cekin

TURKISH JOURNAL OF GASTROENTEROLOGY (2017)

Article Genetics & Heredity

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients

Andrew Brantley Hall et al.

GENOME MEDICINE (2017)

Article Microbiology

Dynamics of the human gut microbiome in inflammatory bowel disease

Jonas Halfvarson et al.

NATURE MICROBIOLOGY (2017)

Review Gastroenterology & Hepatology

Mechanisms of Intestinal Epithelial Barrier Dysfunction by Adherent-Invasive Escherichia coli

Ali Shawki et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn's disease

N. Heerasing et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)

Article Gastroenterology & Hepatology

The gut microbiota and host health: a new clinical frontier

Julian R. Marchesi et al.

Review Gastroenterology & Hepatology

Gut Virome and Inflammatory Bowel Disease

Loris R. Lopetuso et al.

INFLAMMATORY BOWEL DISEASES (2016)

Article Multidisciplinary Sciences

Accounting for reciprocal host-microbiome interactions in experimental science

Thaddeus S. Stappenbeck et al.

NATURE (2016)

Article Multidisciplinary Sciences

Microcins mediate competition among Enterobacteriaceae in the inflamed gut

Martina Sassone-Corsi et al.

NATURE (2016)

Article Medicine, General & Internal

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease

B. G. Feagan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Gastroenterology & Hepatology

Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update

Franco Scaldaferri et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Review Biochemistry & Molecular Biology

Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases

Eddy Owaga et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Immunology

The fungal microbiota of de-novo paediatric inflammatory bowel disease

I. Mukhopadhya et al.

MICROBES AND INFECTION (2015)

Article Multidisciplinary Sciences

The microbiota regulates type 2 immunity through RORγt+ T cells

Caspar Ohnmacht et al.

SCIENCE (2015)

Article Gastroenterology & Hepatology

The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead

Aleksandar D. Kostic et al.

GASTROENTEROLOGY (2014)

Review Gastroenterology & Hepatology

Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis

Ruben J. Colman et al.

JOURNAL OF CROHNS & COLITIS (2014)

Article Gastroenterology & Hepatology

Imbalances of CD4+ T-cell subgroups in Crohn's disease and their relationship with disease activity and prognosis

Kang Chao et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)

Review Microbiology

The gut microbiota, bacterial metabolites and colorectal cancer

Petra Louis et al.

NATURE REVIEWS MICROBIOLOGY (2014)

Article Gastroenterology & Hepatology

Role of the gut microbiota in human nutrition and metabolism

Balakrishnan S. Ramakrishna

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Gastroenterology & Hepatology

The gut microbiota in IBD

Chaysavanh Manichanh et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)